It is well known that AF can lead to endothelial dysfunction21, and Wang reported that the plasma levels of VEGFA were significantly elevated in AF patients22, suggesting that endothelial dysfunction may be one of the etiologies of AF, VEGFA may be a potential therapeutic target for AF. This evidence concerns the gene VEGFA and endothelial dysfunction.